Haemodialysis
Minimising your patientsĢý risks for cardiovascular morbidity and mortality
Despite significant improvements in the quality and efficacy of haemodialysis therapy in recent years, Cardiovascular Disease (CVD) remains the leading cause of death for dialysis patients. Today, almost every other dialysis patient dies from cardiovascular complications. Ģý supports nephrologists worldwide in minimising their patientsĢý risks for cardiovascular morbidity and mortality.
Ģý continuously strives to develop and implement innovative therapies and products to improve the cardiovascular prognosis of dialysis patients.
In this section: